Biomarker ID | 1630 |
PMID | 31031850 |
Year | 2019 |
Biomarker | BIRC5 |
Biomarker Basis | Expression Based |
Biomolecule | mRNA |
Source | Tissue |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | HR: 2.086 |
Effect on Pathways | Pathways include: FOXM1 transcription factor network, Interleukin-4 signaling pathway, Myc active pathway, M phase pathway, Apoptosis modulation and signaling |
Experiment | Biochemical recurrence Vs No Biochemical Recurrence |
Type of Biomarker | Prognostic |
Cohort | 498 cases from TCGA-PRAD were analysed along with 52 normal prostate controls were selected for the analysis |
Senstivity | NA |
Specificity | NA |
AUC | 0.6562 |
Accuracy | NA |
Level Of Significance | p =0.0001304 |
Method Used | NA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |